chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: DTAP, MMR, VARCEL
Symptoms: Blister, Erythema, Rash papular, Skin lesion
Clinical narrative: Rash papular raised pinkish lesions numbering 10-15 on torso perhaps 2 early vesicles noted.
Age: 5.0
Sex: F
Vaccine: UNK
Symptoms: Erythema, Induration, Pruritus, Pyrexia, Swelling
Clinical narrative: Later in the evening after receiving vaccine pt has some swelling, in the morning had redness and hardening of area along with fever of 100.5 and itchiness. Advised Benadryl, Tylenol, cold compresses and observation.
Age: 59.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia, Skin warm, Swelling
Clinical narrative: Rt arm hot, swollen, sl fever, throbbing x 3 days. 11/20 - looked at arm - still red, some swelling, but states better since 11/17.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Crying
Clinical narrative: non-stop crying
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling, warmth at site of injection and pt of arm.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: (L) arm red, swollen, painful-Localized fever
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Erythema, Hypoaesthesia, Injection site swelling, Oedema peripheral, Pain in extremity
Clinical narrative: Pt is a 33 year old who received AVA #6 SC in rt arm on 3 Nov 07 in preparation for upcoming deployment. The following day, other than slight arm soreness he denied any problems On 5 Nov, day 2, he stated he had swelling from the injection site extending down to mid forearm are. The area was red and warm to touch. He also noticed that he had numbness of his whole rt hand. He denied fever, headaches, muscle ache and joint pain. The following day, 6 Nov, he went to the emergency room in which he was given a steroid shot and sent home on oral prednisone for 5 days. The swelling lasted a total of 3 days. Currently, he denies swelling and stated that the feeling in his has has returned to normal. He denied problems with AVA 1-4 but did note problems with AVA #5 in Jan 07. Per records, this shot was given IM In the left arm. The next day he had a golf ball size of localized swelling that looked like a bruise, was red and warm to touch. He reported that the swelling lasted 1-1.5 wks. He denied headache, fever, muscle or joint pain. He does, however, report that at least monthly he will get a recurrent 'bump' at the injection site that would itch and last for 2 days. He stated that it looks like a mosquito bite. He did seek medical attention but was told it was a bite.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Skin warm
Clinical narrative: Pt is a 33 year old who received AVA #6 SC in rt arm on 3 Nov 07 in preparation for upcoming deployment. The following day, other than slight arm soreness he denied any problems On 5 Nov, day 2, he stated he had swelling from the injection site extending down to mid forearm are. The area was red and warm to touch. He also noticed that he had numbness of his whole rt hand. He denied fever, headaches, muscle ache and joint pain. The following day, 6 Nov, he went to the emergency room in which he was given a steroid shot and sent home on oral prednisone for 5 days. The swelling lasted a total of 3 days. Currently, he denies swelling and stated that the feeling in his has has returned to normal. He denied problems with AVA 1-4 but did note problems with AVA #5 in Jan 07. Per records, this shot was given IM In the left arm. The next day he had a golf ball size of localized swelling that looked like a bruise, was red and warm to touch. He reported that the swelling lasted 1-1.5 wks. He denied headache, fever, muscle or joint pain. He does, however, report that at least monthly he will get a recurrent 'bump' at the injection site that would itch and last for 2 days. He stated that it looks like a mosquito bite. He did seek medical attention but was told it was a bite.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Confusional state, Hyperhidrosis, Pallor, Vomiting
Clinical narrative: pt vomited approx 1 min after shots and became very pale, diaphoretic and confused. Vital signs were stable. Recovered after 5-10 minutes of lying on exam table
Age: 34.0
Sex: M
Vaccine: TTOX
Symptoms: Hypoaesthesia, Musculoskeletal pain
Clinical narrative: 3 days after vaccination, patient had pain around the left shoulder with numbness extending from (L) shoulder upto elbow and extending to (L) scapular area; no weakness, DTR - normal. Sensory/Parasthesia to fine and touch.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Decreased appetite, Pyrexia
Clinical narrative: Mother states client began running fever 11/7/07 at night. Grade of fever unknown b/c mother states they do not have thermometer. Client had decreased appetite11/7/07 PM as well. Reports giving Tylenol and alternating with Motrin q 6 hours beginning 11/7/07. States 11/8/07 went to school and was "fine", no fever. She ate good that night but again ran fever at night and gave Tylenol, alternating with Motrin q 6 hrs. States a "red splotchy" rash.
Age: 1.1
Sex: M
Vaccine: DTAP, HEPA, HIBV, IPV
Symptoms: Rash, Rash generalised
Clinical narrative: The next am, noticed rash on clients legs. Mother describes as tiny bumps that are raised, non-itching. States 2 days later, rash has spread all over - to his back, hand, cheeks. Has not used any medication on rash when report was made. States 11/9/07, 1 week 3 days post vaccination, rash is still present, just not as red.
Age: 32.0
Sex: F
Vaccine: HEP
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: 1/2 h after receiving vaccine developed pain and primarily "pinpricks" and tingling from top of shoulder to all left fingertips worse with movement.
Age: 1.03
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Febrile convulsion, Pyrexia, Rash
Clinical narrative: Initial report received on 06 September 2007 from an investigator participating in the above mentioned trial. A 12-month-old male subject had received the following concomitant therapies: a fourth dose, left thigh, intramuscular injection of ActHIB, lot umber not reported; a first dose, left arm, subcutaneous injection of Proquad (lot number not reported); and a fourth dose, right thigh, intramuscular injection of Prevnar, lot number not reported; on 23 August 2007. Study product was not administered. Eight days post-vaccination, the subject developed a fever and subsequently experienced a febrile seizure. Per the investigator, the cause of the fever was "MMRV vaccine." The subject had also experienced a rash (onset date not reported) that was "consistent with MMRV Vaccine." The investigator considered the event of febrile seizure to be related to Proquad. Treatment included Tylenol for fever. The investigator considered the event of seizure an important medical event. The subject recovered from the event and continued in the study trial. Follow-up information received on 01 October 2007 and 02 October 2007. Vaccine lot numbers were reported as follows: ActHIB lot number UF051AA, MMRV lot number 05404; Prevnar lot number B47300A. On 31 August 2007, the subject experienced a seizure described as generalized, tonic-clonic, which stopped within three to four minutes. The subject was taken to the hospital where he had a fever of 103.5 degrees Fahrenheit. Serum glucose was reported to be "fine". No other testing was done. After the seizure, the subject seemed "normal". On 01 September 2007, the subject had a fever of 101.5 degrees Fahrenheit, treated with cold compress. On 02 September 2007, maximum temperature was 100 degrees Fahrenheit and a rash was discovered at that time. The subject was suspected to have ringworm and was given topical Tinactin. When seen on 05 September 2007, the subject's tympanic temperature was 97.6 degrees Fahrenheit. The subject was still receiving Tylenol every four hours. The physician's notes dated 05 September 2007 reported the following diagnoses: "febrile seizure" with suspected cause of fever being the MMR vaccine; "rash, unspecified" (noted more likely to be eczema than tinea) and "viral exanthem", noted to be a fading rash consistent with MMR vaccine. The physician noted that there were a number of faint/fading tiny pink blanching papules on the trunk. There were also several roundish, dry, tannish discolorations on the left arm and thighs; these appeared more eczematoid than tinea-like but neither was readily excluded by inspection. There were no excoriations; normal skin exam otherwise. The physician noted that the timing was right for the fever to have been caused by the MMR vaccine and what remained of the rash was also consistent with that. It was reported that the patchy rash was more likely eczema versus tinea and was not related to the other symptoms or history. Documents held by sender: Physician's notes from office visit on 05 September 2007.
Age: 1.03
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Dry skin, Eczema, Febrile convulsion, Grand mal convulsion, Pallor
Clinical narrative: Initial report received on 06 September 2007 from an investigator participating in the above mentioned trial. A 12-month-old male subject had received the following concomitant therapies: a fourth dose, left thigh, intramuscular injection of ActHIB, lot umber not reported; a first dose, left arm, subcutaneous injection of Proquad (lot number not reported); and a fourth dose, right thigh, intramuscular injection of Prevnar, lot number not reported; on 23 August 2007. Study product was not administered. Eight days post-vaccination, the subject developed a fever and subsequently experienced a febrile seizure. Per the investigator, the cause of the fever was "MMRV vaccine." The subject had also experienced a rash (onset date not reported) that was "consistent with MMRV Vaccine." The investigator considered the event of febrile seizure to be related to Proquad. Treatment included Tylenol for fever. The investigator considered the event of seizure an important medical event. The subject recovered from the event and continued in the study trial. Follow-up information received on 01 October 2007 and 02 October 2007. Vaccine lot numbers were reported as follows: ActHIB lot number UF051AA, MMRV lot number 05404; Prevnar lot number B47300A. On 31 August 2007, the subject experienced a seizure described as generalized, tonic-clonic, which stopped within three to four minutes. The subject was taken to the hospital where he had a fever of 103.5 degrees Fahrenheit. Serum glucose was reported to be "fine". No other testing was done. After the seizure, the subject seemed "normal". On 01 September 2007, the subject had a fever of 101.5 degrees Fahrenheit, treated with cold compress. On 02 September 2007, maximum temperature was 100 degrees Fahrenheit and a rash was discovered at that time. The subject was suspected to have ringworm and was given topical Tinactin. When seen on 05 September 2007, the subject's tympanic temperature was 97.6 degrees Fahrenheit. The subject was still receiving Tylenol every four hours. The physician's notes dated 05 September 2007 reported the following diagnoses: "febrile seizure" with suspected cause of fever being the MMR vaccine; "rash, unspecified" (noted more likely to be eczema than tinea) and "viral exanthem", noted to be a fading rash consistent with MMR vaccine. The physician noted that there were a number of faint/fading tiny pink blanching papules on the trunk. There were also several roundish, dry, tannish discolorations on the left arm and thighs; these appeared more eczematoid than tinea-like but neither was readily excluded by inspection. There were no excoriations; normal skin exam otherwise. The physician noted that the timing was right for the fever to have been caused by the MMR vaccine and what remained of the rash was also consistent with that. It was reported that the patchy rash was more likely eczema versus tinea and was not related to the other symptoms or history. Documents held by sender: Physician's notes from office visit on 05 September 2007.
Age: 1.03
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Pyrexia, Rash, Rash papular, Skin discolouration, Tinea infection
Clinical narrative: Initial report received on 06 September 2007 from an investigator participating in the above mentioned trial. A 12-month-old male subject had received the following concomitant therapies: a fourth dose, left thigh, intramuscular injection of ActHIB, lot umber not reported; a first dose, left arm, subcutaneous injection of Proquad (lot number not reported); and a fourth dose, right thigh, intramuscular injection of Prevnar, lot number not reported; on 23 August 2007. Study product was not administered. Eight days post-vaccination, the subject developed a fever and subsequently experienced a febrile seizure. Per the investigator, the cause of the fever was "MMRV vaccine." The subject had also experienced a rash (onset date not reported) that was "consistent with MMRV Vaccine." The investigator considered the event of febrile seizure to be related to Proquad. Treatment included Tylenol for fever. The investigator considered the event of seizure an important medical event. The subject recovered from the event and continued in the study trial. Follow-up information received on 01 October 2007 and 02 October 2007. Vaccine lot numbers were reported as follows: ActHIB lot number UF051AA, MMRV lot number 05404; Prevnar lot number B47300A. On 31 August 2007, the subject experienced a seizure described as generalized, tonic-clonic, which stopped within three to four minutes. The subject was taken to the hospital where he had a fever of 103.5 degrees Fahrenheit. Serum glucose was reported to be "fine". No other testing was done. After the seizure, the subject seemed "normal". On 01 September 2007, the subject had a fever of 101.5 degrees Fahrenheit, treated with cold compress. On 02 September 2007, maximum temperature was 100 degrees Fahrenheit and a rash was discovered at that time. The subject was suspected to have ringworm and was given topical Tinactin. When seen on 05 September 2007, the subject's tympanic temperature was 97.6 degrees Fahrenheit. The subject was still receiving Tylenol every four hours. The physician's notes dated 05 September 2007 reported the following diagnoses: "febrile seizure" with suspected cause of fever being the MMR vaccine; "rash, unspecified" (noted more likely to be eczema than tinea) and "viral exanthem", noted to be a fading rash consistent with MMR vaccine. The physician noted that there were a number of faint/fading tiny pink blanching papules on the trunk. There were also several roundish, dry, tannish discolorations on the left arm and thighs; these appeared more eczematoid than tinea-like but neither was readily excluded by inspection. There were no excoriations; normal skin exam otherwise. The physician noted that the timing was right for the fever to have been caused by the MMR vaccine and what remained of the rash was also consistent with that. It was reported that the patchy rash was more likely eczema versus tinea and was not related to the other symptoms or history. Documents held by sender: Physician's notes from office visit on 05 September 2007.
Age: 1.03
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Viral rash
Clinical narrative: Initial report received on 06 September 2007 from an investigator participating in the above mentioned trial. A 12-month-old male subject had received the following concomitant therapies: a fourth dose, left thigh, intramuscular injection of ActHIB, lot umber not reported; a first dose, left arm, subcutaneous injection of Proquad (lot number not reported); and a fourth dose, right thigh, intramuscular injection of Prevnar, lot number not reported; on 23 August 2007. Study product was not administered. Eight days post-vaccination, the subject developed a fever and subsequently experienced a febrile seizure. Per the investigator, the cause of the fever was "MMRV vaccine." The subject had also experienced a rash (onset date not reported) that was "consistent with MMRV Vaccine." The investigator considered the event of febrile seizure to be related to Proquad. Treatment included Tylenol for fever. The investigator considered the event of seizure an important medical event. The subject recovered from the event and continued in the study trial. Follow-up information received on 01 October 2007 and 02 October 2007. Vaccine lot numbers were reported as follows: ActHIB lot number UF051AA, MMRV lot number 05404; Prevnar lot number B47300A. On 31 August 2007, the subject experienced a seizure described as generalized, tonic-clonic, which stopped within three to four minutes. The subject was taken to the hospital where he had a fever of 103.5 degrees Fahrenheit. Serum glucose was reported to be "fine". No other testing was done. After the seizure, the subject seemed "normal". On 01 September 2007, the subject had a fever of 101.5 degrees Fahrenheit, treated with cold compress. On 02 September 2007, maximum temperature was 100 degrees Fahrenheit and a rash was discovered at that time. The subject was suspected to have ringworm and was given topical Tinactin. When seen on 05 September 2007, the subject's tympanic temperature was 97.6 degrees Fahrenheit. The subject was still receiving Tylenol every four hours. The physician's notes dated 05 September 2007 reported the following diagnoses: "febrile seizure" with suspected cause of fever being the MMR vaccine; "rash, unspecified" (noted more likely to be eczema than tinea) and "viral exanthem", noted to be a fading rash consistent with MMR vaccine. The physician noted that there were a number of faint/fading tiny pink blanching papules on the trunk. There were also several roundish, dry, tannish discolorations on the left arm and thighs; these appeared more eczematoid than tinea-like but neither was readily excluded by inspection. There were no excoriations; normal skin exam otherwise. The physician noted that the timing was right for the fever to have been caused by the MMR vaccine and what remained of the rash was also consistent with that. It was reported that the patchy rash was more likely eczema versus tinea and was not related to the other symptoms or history. Documents held by sender: Physician's notes from office visit on 05 September 2007.
Age: 1.0
Sex: M
Vaccine: MMRV, MNQ, MMRV, MNQ
Symptoms: Body temperature increased, Grand mal convulsion, Inappropriate schedule of drug administration, Pyrexia
Clinical narrative: Initial report received on 05 October 2007 from an investigator participating in the above-mentioned trial. A 12-month-old male subject experienced a febrile seizure 19 days after receiving an intramuscular right thigh injection of Menactra (dose two, lot number U2172AA) and a subcutaneous left arm injection of MMRV (dose one, lot number 1482F). On 22 September 2007, the subject developed a fever "but was acting fine", and his parents treated him with Tylenol. On 23 September 2007, the subject developed a rectal temperature of 104.9 degrees Fahrenheit, and experienced a grand-mal seizure lasting "a few minutes". He was noted to be post-ictal for five minutes following the seizure. The seizure was reported by his mother, who was a pediatrician. His parents treated his fever with Tylenol and a sponge bath, and the fever resolved the following day. No additional seizures were noted. Per the investigator, the subject had no history of febrile seizures. He recovered and continued in the trial. According to the investigator, the event was not related to Menactra. The investigator considered the event to be related to the MMRV vaccine (measles, mumps, rubella, varicella). Initial information for this case was received on 05 October 2007. On 08 October 2007, additional information was received from the investigator which upgraded the causality for MMRV from "not related" to "related".
Age: 1.0
Sex: M
Vaccine: MMRV, MNQ, MMRV, MNQ
Symptoms: Body temperature increased, Febrile convulsion, Grand mal convulsion, Inappropriate schedule of drug administration, Medication error
Clinical narrative: Initial report received on 05 October 2007 from an investigator participating in the above-mentioned trial. A 12-month-old male subject experienced a febrile seizure 19 days after receiving an intramuscular right thigh injection of Menactra (dose two, lot number U2172AA) and a subcutaneous left arm injection of MMRV (dose one, lot number 1482F). On 22 September 2007, the subject developed a fever "but was acting fine", and his parents treated him with Tylenol. On 23 September 2007, the subject developed a rectal temperature of 104.9 degrees Fahrenheit, and experienced a grand-mal seizure lasting "a few minutes". He was noted to be post-ictal for five minutes following the seizure. The seizure was reported by his mother, who was a pediatrician. His parents treated his fever with Tylenol and a sponge bath, and the fever resolved the following day. No additional seizures were noted. Per the investigator, the subject had no history of febrile seizures. He recovered and continued in the trial. According to the investigator, the event was not related to Menactra. The investigator considered the event to be related to the MMRV vaccine (measles, mumps, rubella, varicella). Initial information for this case was received on 05 October 2007. On 08 October 2007, additional information was received from the investigator which upgraded the causality for MMRV from "not related" to "related".
Age: 1.0
Sex: M
Vaccine: MMRV, MNQ, MMRV, MNQ
Symptoms: Postictal state, Pyrexia, Wrong drug administered
Clinical narrative: Initial report received on 05 October 2007 from an investigator participating in the above-mentioned trial. A 12-month-old male subject experienced a febrile seizure 19 days after receiving an intramuscular right thigh injection of Menactra (dose two, lot number U2172AA) and a subcutaneous left arm injection of MMRV (dose one, lot number 1482F). On 22 September 2007, the subject developed a fever "but was acting fine", and his parents treated him with Tylenol. On 23 September 2007, the subject developed a rectal temperature of 104.9 degrees Fahrenheit, and experienced a grand-mal seizure lasting "a few minutes". He was noted to be post-ictal for five minutes following the seizure. The seizure was reported by his mother, who was a pediatrician. His parents treated his fever with Tylenol and a sponge bath, and the fever resolved the following day. No additional seizures were noted. Per the investigator, the subject had no history of febrile seizures. He recovered and continued in the trial. According to the investigator, the event was not related to Menactra. The investigator considered the event to be related to the MMRV vaccine (measles, mumps, rubella, varicella). Initial information for this case was received on 05 October 2007. On 08 October 2007, additional information was received from the investigator which upgraded the causality for MMRV from "not related" to "related".
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, UNK, HPV4, MEN
Symptoms: Ataxia, Azotaemia, Blood creatinine increased, Blood urea increased, Diplopia
Clinical narrative: 6 day history of double vision, 4 day history of unsteady gait and weakness in extremities (right side greater than left).
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, UNK, HPV4, MEN
Symptoms: Leukoencephalomyelitis, Muscular weakness, Nuclear magnetic resonance imaging brain abnormal
Clinical narrative: 6 day history of double vision, 4 day history of unsteady gait and weakness in extremities (right side greater than left).
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, UNK, HPV4, MEN
Symptoms: Brain oedema, Diplopia
Clinical narrative: 6 day history of double vision, 4 day history of unsteady gait and weakness in extremities (right side greater than left).
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, UNK, HPV4, MEN
Symptoms: Chest X-ray normal, Computerised tomogram normal, Diplopia, Encephalopathy, Gait disturbance
Clinical narrative: 6 day history of double vision, 4 day history of unsteady gait and weakness in extremities (right side greater than left).
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, UNK, HPV4, MEN
Symptoms: Glioma, Meningitis, Muscular weakness, Nuclear magnetic resonance imaging abnormal
Clinical narrative: 6 day history of double vision, 4 day history of unsteady gait and weakness in extremities (right side greater than left).
Age: 64.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Asthenia, Guillain-Barre syndrome, Intensive care, Mechanical ventilation, Respiratory failure
Clinical narrative: Patient arrived to the hospital on 11/03/2007 complaining of epigastric pain and weakness of the lower extremities. On 11/12/2007 patient developed respiratory distress and was intubated. Patient was transfered to ICU intubated, lethargic and unable to move upper and lower extremities.
Age: 64.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Abdominal pain upper, CSF glucose increased, CSF protein increased, Cytomegalovirus antibody, Epstein-Barr virus antibody
Clinical narrative: Patient arrived to the hospital on 11/03/2007 complaining of epigastric pain and weakness of the lower extremities. On 11/12/2007 patient developed respiratory distress and was intubated. Patient was transfered to ICU intubated, lethargic and unable to move upper and lower extremities.
Age: 64.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Gram stain negative, Intensive care, Intubation, Lethargy, Movement disorder
Clinical narrative: Patient arrived to the hospital on 11/03/2007 complaining of epigastric pain and weakness of the lower extremities. On 11/12/2007 patient developed respiratory distress and was intubated. Patient was transfered to ICU intubated, lethargic and unable to move upper and lower extremities.
Age: 64.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Muscular weakness, Respiratory distress
Clinical narrative: Patient arrived to the hospital on 11/03/2007 complaining of epigastric pain and weakness of the lower extremities. On 11/12/2007 patient developed respiratory distress and was intubated. Patient was transfered to ICU intubated, lethargic and unable to move upper and lower extremities.
Age: 28.0
Sex: M
Vaccine: TDAP
Symptoms: Abnormal dreams, Fatigue, Hallucination, Headache, Myalgia
Clinical narrative: Approx 24 hours after vaccination, patient developed noticable fatigue, muscle soreness (injection point and throughout entire body).  Nausea and headache presented at approx. 27 hours post-vaccination.  At 30 hour mark, patient developed fever (99.9) and overall shakiness.  For next 8 hours, all symptoms continued including a fever spike at 102.1.  Patient also exhibited mild hallucinations/dreams that were extremely vivid; difficult for patient to differentiate between real and hallucinations.  After approx. 40 hours past, fever began to break and symptoms slowly subsided.  Headache, minor nausea and low-grade fever persisted.  Patient returned to normal after 48 hours.
Age: 28.0
Sex: M
Vaccine: TDAP
Symptoms: Nausea, Pyrexia, Tremor
Clinical narrative: Approx 24 hours after vaccination, patient developed noticable fatigue, muscle soreness (injection point and throughout entire body).  Nausea and headache presented at approx. 27 hours post-vaccination.  At 30 hour mark, patient developed fever (99.9) and overall shakiness.  For next 8 hours, all symptoms continued including a fever spike at 102.1.  Patient also exhibited mild hallucinations/dreams that were extremely vivid; difficult for patient to differentiate between real and hallucinations.  After approx. 40 hours past, fever began to break and symptoms slowly subsided.  Headache, minor nausea and low-grade fever persisted.  Patient returned to normal after 48 hours.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Rash, Swelling, Urticaria
Clinical narrative: swelling, rash, and hives on left side of body appearing 24 hrs after injection.  Treated with Benadryl and epinephrine.  Resolved within 24 hrs.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: None. Vaccine not approved for age group.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: None. Vaccine not approved for age group.
Age: 61.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Dysphonia, Neck pain, Pain, Pharyngeal oedema
Clinical narrative: The evening of the day of the vaccine, I began to feel achy, more so in my neck, but generally all over. The following day, I had fever, chills, hoarseness and my throat felt 'swollen', and again had aches all over my body.
Age: 61.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: The evening of the day of the vaccine, I began to feel achy, more so in my neck, but generally all over. The following day, I had fever, chills, hoarseness and my throat felt 'swollen', and again had aches all over my body.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: None. Vaccine not approved for age group.
Age: 26.0
Sex: F
Vaccine: FLUN3
Symptoms: Dizziness, Fatigue, Headache, Nasal congestion, Pharyngolaryngeal pain
Clinical narrative: Headaches, nasal congestion, fatigue, sore throat, lightheadedness began 1 day after receiving FluMist vaccine, persisting at day 5 post dose.
Age: 86.0
Sex: M
Vaccine: FLU3
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Pt developed vesicular rash on the same arm that he received the flu vaccine, 2 days after receiving vaccine. Pt did not report rash until 11/15 and presented to office on 11/20. Pt diagnosied with Shingles and started on valcyclovir 1g tid.  Pt with vesicular rash over entire Right arm and scapula region
Age: 0.3
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Crying, Cyanosis, Listless
Clinical narrative: parents state patient was "blue around the mouth" after crying out in sleep and very listless.  Color improved within 45minutes and no further occurances report throughout the night.  Followed up the next morning in office on 11/21/07 with Dr. and was instructed not to recieve Pertussis vaccine in future.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: None. Vaccine not approved for age group.
Age: 11.0
Sex: M
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: None. Vaccine not approved for age group.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Cellulitis, Injection site erythema, Skin warm, Swelling, Tenderness
Clinical narrative: Redness at injection site. Slight swelling, warm to touch, slightly tender. Started looking like cellulitis, given Keflex 250mg/5ml 5ml tid 10 days.
Age: 0.25
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PPV
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: No adverse events per parent - contacted on afternoon 10/31/2007. Reporting due to Influenza Vaccine administered before 6 mo. of age per recommendation of CDC Info. Contact Service #1-43674577.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: large ovoid area erythema, wrmth, tenderness, induration extending ditally from injection site R UE, area marked.  Given rx for Keflex.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Infection, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: 11-15-07 1553 Client received flu shot at 1553 Sanofi Lot U2502AA in left deltoid IM.  11-19-07 Mom came into office in afternoon and told clerical the patient had to go to the Dr. on Saturday November 17, 2007 because the spot where he got the flu shot was all red.  The Dr. told her it was an infection.  11-20-07 1120 Left message at client's house for mom to return my call and let me know details of what happened. 11-20-07  Saw client's mom in evening at flu clinic and she reported details to me.  She stated on Friday November 16 her son (client) told her that his arm itched.  On Saturday November 17 her son was getting dressed and felt a bump on his arm.  He went to show his mom and she stated it was red, warm and sore.  No fever was present.  Mom felt the redness was the size of an orange or a grapefruit.  She took him to acute care in the am and he saw a PA.  He was given an antibiotic.  Mom is unsure of the name but knew it started with a 'C'.  He was prescribed 10 days worth for three times a day.  She gave him two doses on Saturday and by Sunday the redness was the size of a dime.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus
Clinical narrative: 11-15-07 1553 Client received flu shot at 1553 Sanofi Lot U2502AA in left deltoid IM.  11-19-07 Mom came into office in afternoon and told clerical the patient had to go to the Dr. on Saturday November 17, 2007 because the spot where he got the flu shot was all red.  The Dr. told her it was an infection.  11-20-07 1120 Left message at client's house for mom to return my call and let me know details of what happened. 11-20-07  Saw client's mom in evening at flu clinic and she reported details to me.  She stated on Friday November 16 her son (client) told her that his arm itched.  On Saturday November 17 her son was getting dressed and felt a bump on his arm.  He went to show his mom and she stated it was red, warm and sore.  No fever was present.  Mom felt the redness was the size of an orange or a grapefruit.  She took him to acute care in the am and he saw a PA.  He was given an antibiotic.  Mom is unsure of the name but knew it started with a 'C'.  He was prescribed 10 days worth for three times a day.  She gave him two doses on Saturday and by Sunday the redness was the size of a dime.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: Pt got dizzy after Gardasil injection.  Given ammonia pellet and juice, rested in clinic for 20 minutes.  Left alerted and oriented.  BP  100/60 Pulse 66 Resp 16 even and unlabored.
Age: 48.0
Sex: F
Vaccine: FLUX, TD
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient presented to clinic with the following adverse drug reactions; injection site of her right upper arm began to hurt at night,swell, and became red.  Patient received tetanus vaccine and flu or pneumovax.  Unknown if patient received the vaccination at clinic.
Age: 20.0
Sex: M
Vaccine: MMR
Symptoms: Nasal congestion, Rhinorrhoea, Urticaria
Clinical narrative: Within 30 minutes of vaccination, patent began to experience profuse nasal drainage and significant nasal congestion.  Patent broke out in hives. Patent took Benidril and Pepsid, and symptoms subsequently disappeared within an hour.
Age: 23.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Muscle spasms, Myalgia
Clinical narrative: severe myalgias at night and in am after vaccine, resulting in muscle cramping of hands and feet and "locking" of ankles and elbows. Upon waking in am was so impaired that she had to crawl to phone but regained mobility within 1/2 hour.  Function nl by 24 hours, Sx resolved by 36 hours
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Cellulitis, Erythema, Injection site cellulitis, Injection site discharge, Injection site erythema
Clinical narrative: Received IM vaccine 11/09.  Had latent side effect on 11/13 - noted hard redden area surrounding injection site, the size of a  quarter, swollen and raised.  Referred to MD. MD ordered oral antibiotics and administered 2 Rocephin IM's. Diagnosis of cellulitis. 11/14 noted increased swelling, redden rash radiated down the biceps.  Admitted patient for IV antibotic therapy vancomyacin.  Hospitalized 2 days.  Taken off vancomyacin as of 11/21/07.  Will continue on oral antibotics.  The right deltoid is still visabily slightly redden and swollen; the muscle feels somewhat harder than right deltoid muscle and has one minute areas of serous leakage which is covered with a bandaid.   No tunneling.  Pain has alleviated and is only noted in right upper deltoid.  ROM normal today.  Will continue monitoring of site and stay on oral antibotics12/3/07-records received  for DOS 11/14-11/16/07-DC DX: Right upper arm cellulitis. Increasing redness and swelling and pain.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site induration, Injection site swelling, Muscle tightness, Pain in extremity, Rash
Clinical narrative: Received IM vaccine 11/09.  Had latent side effect on 11/13 - noted hard redden area surrounding injection site, the size of a  quarter, swollen and raised.  Referred to MD. MD ordered oral antibiotics and administered 2 Rocephin IM's. Diagnosis of cellulitis. 11/14 noted increased swelling, redden rash radiated down the biceps.  Admitted patient for IV antibotic therapy vancomyacin.  Hospitalized 2 days.  Taken off vancomyacin as of 11/21/07.  Will continue on oral antibotics.  The right deltoid is still visabily slightly redden and swollen; the muscle feels somewhat harder than right deltoid muscle and has one minute areas of serous leakage which is covered with a bandaid.   No tunneling.  Pain has alleviated and is only noted in right upper deltoid.  ROM normal today.  Will continue monitoring of site and stay on oral antibotics12/3/07-records received  for DOS 11/14-11/16/07-DC DX: Right upper arm cellulitis. Increasing redness and swelling and pain.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Burning sensation, Injection site pruritus, Pyrexia, Rash generalised
Clinical narrative: Approx. 1-2 hrs after flu vaccine, employee noticed arm where vacccine administered itching, then became aware of itching, stinging rash over entire body.Sts fever next day, abd discomfort since onset.Employee seen 5 days after symptom onset-treated with tapering dose Prednisone, Zantac OTC suggested.Offered eval by Wrk Md.11/20/07, empl. chose to come here to Empl. Health office.
Age: 73.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Pt stated that arm became swollen, red, hot, itchy and tender from appoximately 2-3inches below injection site to the elbow.  Pt used cold compresses and Tylenol without relief. Pt went to his PMD who ordered Levaquin 500mg po x 7 days.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Expired drug administered
Clinical narrative: PT. GIVEN EXPIRED DOSE OF MMR FOR 2ND DOSE. PT. NOTIFIED THAT THIS VACCINATION IS INVALID AND THAT SHE WILL NEED TO COME IN FOR REVACCINATION AFTER 4 WKS.
Age: 7.0
Sex: F
Vaccine: FLU3, HEPA, VARCEL
Symptoms: Alopecia, Anaemia, Arthralgia, Chest X-ray normal, Computerised tomogram normal
Clinical narrative: Within a week of the vaccination, she was tired, and she had a few nose bleeds (that were hard to stop). Her gums started bleeding when brushing her teeth a few weeks after the vaccine. She then started having high fevers around October 31, 2006,(103, 104, 105)and was eventually hospitalized on November 7, 2007, after a blood test revealed that her blood platelet count was down to 16,000. She had two chest x-rays that were normal. She was diagnosed as having high fever, a low platelet count (platelets got as low as 7,000), and low red blood cells count (which resulted in anemia). While hospitalized, she was twice treated with IVIG that caused her platelet count to rise. She also received intravenous antibiotic treatments that she did not respond to. She was also given Tylenol and later Motrin while hospitalized to control the fever. She is now taking Prednisone for a short period. In addition, she is taking iron pills and Protonix (to protect her stomach from the affects of the steroid medicine). While hospitalized, she also had a CAT Scan (of the head) and ultrasounds of her abdominal area (tests were normal).  12/06/2007 MR received for DOS 11/7-17/2007 with D/C DX:  Evan's Syndrome. Presented to local ED with fever x days, thrombocytopenia and anemia. Pt initially developed cough, rhinorrhea, fatigue and fever. Treated symptomatically for suspected viral infection.  Pt developed increasing fatigue and difficulty leaving bed.  Seen again by PCP with labs and CXR done.  Admitted for further w/u of FUO and thromobcytopenia.  PE (+) for purpura of the external ear, lip ecchymosis (blood blisters), violaceous scaly skin patches involving the malar eminence, and upper extremities. Started on abx and IVIG PMH: Skin disorder x 1.5-2 yrs c/w granuloma annulare.  Rash on face/cutaneous lesions c/w Lupus.  Constipation.  Recurrent sinus infections. Pt developed nausea, dizziness and blurred vision and had a near syncopal episode.  New onset RUQ pain on day 8 with increased LFTs.  Multiple consults by Heme/Onc, Rheum, GI, Neuro and ID. DX of Evan's Syndrome on Day 10 and tx with steroids begun to be continued and F/U as outpt. Per 60 day follow up: She is still experiencing low platelets, which is being controlled by steroid usage (presnisone). 1/15/2010 Patient rec'd other vaccine, hep A on 7/31/08 and she had to be readmitted to the hospital she experienced hair loss, skin rash, fevers, low plackets and joint pain.
Age: 7.0
Sex: F
Vaccine: FLU3, HEPA, VARCEL
Symptoms: Constipation, Epistaxis, Fatigue, Gingival bleeding, Granuloma annulare
Clinical narrative: Within a week of the vaccination, she was tired, and she had a few nose bleeds (that were hard to stop). Her gums started bleeding when brushing her teeth a few weeks after the vaccine. She then started having high fevers around October 31, 2006,(103, 104, 105)and was eventually hospitalized on November 7, 2007, after a blood test revealed that her blood platelet count was down to 16,000. She had two chest x-rays that were normal. She was diagnosed as having high fever, a low platelet count (platelets got as low as 7,000), and low red blood cells count (which resulted in anemia). While hospitalized, she was twice treated with IVIG that caused her platelet count to rise. She also received intravenous antibiotic treatments that she did not respond to. She was also given Tylenol and later Motrin while hospitalized to control the fever. She is now taking Prednisone for a short period. In addition, she is taking iron pills and Protonix (to protect her stomach from the affects of the steroid medicine). While hospitalized, she also had a CAT Scan (of the head) and ultrasounds of her abdominal area (tests were normal).  12/06/2007 MR received for DOS 11/7-17/2007 with D/C DX:  Evan's Syndrome. Presented to local ED with fever x days, thrombocytopenia and anemia. Pt initially developed cough, rhinorrhea, fatigue and fever. Treated symptomatically for suspected viral infection.  Pt developed increasing fatigue and difficulty leaving bed.  Seen again by PCP with labs and CXR done.  Admitted for further w/u of FUO and thromobcytopenia.  PE (+) for purpura of the external ear, lip ecchymosis (blood blisters), violaceous scaly skin patches involving the malar eminence, and upper extremities. Started on abx and IVIG PMH: Skin disorder x 1.5-2 yrs c/w granuloma annulare.  Rash on face/cutaneous lesions c/w Lupus.  Constipation.  Recurrent sinus infections. Pt developed nausea, dizziness and blurred vision and had a near syncopal episode.  New onset RUQ pain on day 8 with increased LFTs.  Multiple consults by Heme/Onc, Rheum, GI, Neuro and ID. DX of Evan's Syndrome on Day 10 and tx with steroids begun to be continued and F/U as outpt. Per 60 day follow up: She is still experiencing low platelets, which is being controlled by steroid usage (presnisone). 1/15/2010 Patient rec'd other vaccine, hep A on 7/31/08 and she had to be readmitted to the hospital she experienced hair loss, skin rash, fevers, low plackets and joint pain.
Age: 7.0
Sex: F
Vaccine: FLU3, HEPA, VARCEL
Symptoms: Immunoglobulins, Laboratory test, Laboratory test normal, Lip blister, Platelet count decreased
Clinical narrative: Within a week of the vaccination, she was tired, and she had a few nose bleeds (that were hard to stop). Her gums started bleeding when brushing her teeth a few weeks after the vaccine. She then started having high fevers around October 31, 2006,(103, 104, 105)and was eventually hospitalized on November 7, 2007, after a blood test revealed that her blood platelet count was down to 16,000. She had two chest x-rays that were normal. She was diagnosed as having high fever, a low platelet count (platelets got as low as 7,000), and low red blood cells count (which resulted in anemia). While hospitalized, she was twice treated with IVIG that caused her platelet count to rise. She also received intravenous antibiotic treatments that she did not respond to. She was also given Tylenol and later Motrin while hospitalized to control the fever. She is now taking Prednisone for a short period. In addition, she is taking iron pills and Protonix (to protect her stomach from the affects of the steroid medicine). While hospitalized, she also had a CAT Scan (of the head) and ultrasounds of her abdominal area (tests were normal).  12/06/2007 MR received for DOS 11/7-17/2007 with D/C DX:  Evan's Syndrome. Presented to local ED with fever x days, thrombocytopenia and anemia. Pt initially developed cough, rhinorrhea, fatigue and fever. Treated symptomatically for suspected viral infection.  Pt developed increasing fatigue and difficulty leaving bed.  Seen again by PCP with labs and CXR done.  Admitted for further w/u of FUO and thromobcytopenia.  PE (+) for purpura of the external ear, lip ecchymosis (blood blisters), violaceous scaly skin patches involving the malar eminence, and upper extremities. Started on abx and IVIG PMH: Skin disorder x 1.5-2 yrs c/w granuloma annulare.  Rash on face/cutaneous lesions c/w Lupus.  Constipation.  Recurrent sinus infections. Pt developed nausea, dizziness and blurred vision and had a near syncopal episode.  New onset RUQ pain on day 8 with increased LFTs.  Multiple consults by Heme/Onc, Rheum, GI, Neuro and ID. DX of Evan's Syndrome on Day 10 and tx with steroids begun to be continued and F/U as outpt. Per 60 day follow up: She is still experiencing low platelets, which is being controlled by steroid usage (presnisone). 1/15/2010 Patient rec'd other vaccine, hep A on 7/31/08 and she had to be readmitted to the hospital she experienced hair loss, skin rash, fevers, low plackets and joint pain.